Written Exposure Therapy for Veterans with Substance Use Disorders and PTSD
Official title: Written Exposure Therapy (WET) as a Brief Trauma Treatment for Veterans With Co-occurring Substance Use Disorders and PTSD
Run by VA Office of Research and Development · NCT05327504 · Data updated 2026-11-12
This study is testing if written exposure therapy can help veterans with substance use disorders and PTSD feel better and improve their recovery compared to a standard treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (West Haven, Connecticut) |
| Status | Recruiting |
| Started | September 26, 2022 |
| Main results expected | May 12, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT05327504 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Veterans aged 18 and older who have a diagnosis of both substance use disorder and PTSD.
✕Probably not a fit
Patients with schizophrenia, severe mood disorders, or those who have recently undergone specific PTSD therapies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project evaluates the effectiveness of written exposure therapy (WET) for Veterans undergoing treatment for substance use disorders (SUD) who also have posttraumatic stress disorder (PTSD). The study involves a randomized clinical trial where participants will receive either WET combined with standard treatment or a neutral writing condition alongside standard treatment. The aim is to determine if WET can significantly reduce PTSD symptoms and improve addiction outcomes compared to the control group. Assessments will be conducted at multiple time points to measure changes in trauma symptoms, distress, and mood.
Why it matters
Potential benefit: If successful, this therapy could provide Veterans with a novel and effective approach to simultaneously address both PTSD and substance use disorders.
How similar studies have gone: Previous studies have shown promising results for written exposure therapy in similar populations, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Veterans ages 18 years old or older; * Meets DSM-5 criteria for at least one substance use disorder (SUD); * Meets DSM-5 criteria for PTSD; * Approved for SUD treatment at VA Connecticut Healthcare System. Exclusion Criteria: * Veterans who meet current criteria for schizophrenia, schizophrenia-type disorders, or unmedicated mania or bipolar disorder as determined by QuickSCID-5; * current suicidal or homicidal risks necessitating a higher level of care; * Veterans who have received an Evidence-Based Psychotherapy for PTSD protocol within the past 6 months; * Problems that would prevent a participant from completing the writing intervention or study assessments (e.g., illiteracy). To assess for literacy, participants will read parts of the consent out loud.
Where it's running
-
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Sarah Meshberg-Cohen, PhD MS BS — VA Connecticut Healthcare System West Haven Campus, West Haven, CT
- Study coordinator: Vera Bici, BA
- Email: Vera.Bici@va.gov
- Phone: (203) 932-5711
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Interdisciplinary support to smooth care transitions for hospitalized adults with substance use disorders
This study tests a team-based in-hospital and post-discharge program to help adults with substance use disorders move from hospital care to ongoing community treatment.
-
Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) for re-entry
This trial tests a multicomponent program called MISSION-CJ with Peer Linkage Support to help adults released from two Massachusetts jails who have both mental health and substance use disorders.
-
Helping toddlers of caregivers with substance use disorders build language skills with group and individualized parenting supports
This project will test whether adding coaching and one-on-one lessons to a group parenting program helps toddlers (12–42 months) of caregivers with substance use disorders develop better language skills.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.